Jasper Therapeutics Inc (JSPR)

02:20 AM

Jasper Therapeutics, Inc. (NASDAQ:JSPR) Receives $29.75 Average Target Price from Analysts - Defense World

02:20 AM

12:00 PM

Jasper Therapeutics Inc. Stock Analysis and ForecastSkyrocketing profit margins - jammulinksnews.com

12:00 PM

Jul 22, 2025

What drives Jasper Therapeutics Inc. stock priceUnrivaled growth potential - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

What drives Jasper Therapeutics Inc. Equity Warrant stock priceFree Market Volatility Navigation Tips - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

Is Jasper Therapeutics Inc. Equity Warrant a good long term investmentFree Stock Market Return Analysis - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

What analysts say about Jasper Therapeutics Inc. stockMarket-beating performance - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

What analysts say about Jasper Therapeutics Inc. Equity Warrant stockUnmatched profit growth - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Jasper Therapeutics, Inc.JSPR - PR Newswire

Jul 22, 2025

Jul 21, 2025

Jasper Therapeutics Inc. Equity Warrant Stock Analysis and ForecastFree Investment Portfolio Suggestions - Autocar Professional

Jul 21, 2025

Jul 20, 2025

Is Jasper Therapeutics Inc. a good long term investmentJaw-dropping returns - Autocar Professional

Jul 20, 2025

Jul 20, 2025

Trading (JSPR) With Integrated Risk Controls - news.stocktradersdaily.com

Jul 20, 2025

Jul 19, 2025

Layoff Tracker: Following Challenges With DMD Therapy, Sarepta Will Cut 500 Employees - BioSpace

Jul 19, 2025

Jul 18, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Jasper Therapeutics, Inc. - GlobeNewswire Inc.

Jul 18, 2025

Jul 17, 2025

Jasper Therapeutics’ SWOT analysis: briquilimab stock faces pivotal moment - Investing.com

Jul 17, 2025

Jul 15, 2025

Finance Watch: Karyopharm Cuts Jobs In Cash Crunch; Pacira’s Layoffs Attributed To Efficiency - insights.citeline.com

Jul 15, 2025

Jul 14, 2025

Bay Area biotech company's drug mishap leads to dozens of layoffs - SFGATE

Jul 14, 2025

Jul 14, 2025

HC Wainwright Issues Positive Estimate for JSPR Earnings - Defense World

Jul 14, 2025

Jul 12, 2025

Jasper Therapeutics' Data Crisis and the Investor's Dilemma: Fraud or Unfortunate Setback? - AInvest

Jul 12, 2025

Jul 12, 2025

Jasper Therapeutics price target lowered to $12 from $70 at Citizens JMP - MSN

Jul 12, 2025

Jul 11, 2025

Redwood City's Jasper Therapeutics Valuation Tumbles Amid Clinical Trial Setbacks and Layoffs - Hoodline

Jul 11, 2025

Jul 11, 2025

Jasper Therapeutics shares fall 1.99% after-hours as Schall Law Firm investigates securities law violations. - AInvest

Jul 11, 2025

Jul 11, 2025

JSPR Investors Have Opportunity to Join Jasper Therapeutics, Inc. Fraud Investigation with the Schall Law Firm - Business Wire

Jul 11, 2025

Jul 10, 2025

Jasper Therapeutics stock holds Market Outperform rating at JMP despite setback - Investing.com Canada

Jul 10, 2025

Jul 10, 2025

Jasper Therapeutics Announces Major Corporate Reorganization - The Globe and Mail

Jul 10, 2025

Jul 10, 2025

BMO Capital Markets Reaffirms “Market Perform” Rating for Jasper Therapeutics (NASDAQ:JSPR) - Defense World

Jul 10, 2025

Jul 10, 2025

Jasper Therapeutics cuts workforce by 50% to focus on urticaria programs - Investing.com South Africa

Jul 10, 2025

Jul 09, 2025

Where are the Opportunities in (JSPR) - news.stocktradersdaily.com

Jul 09, 2025

Jul 09, 2025

Peninsula biotech Jasper Therapeutics to lay off half its staff as cash runs lowSan Francisco Business Times - The Business Journals

Jul 09, 2025

Jul 09, 2025

Jasper Therapeutics Announces Corporate Reorganization and Other Cost Cutting Measures to Extend Cash Runway - MarketScreener

Jul 09, 2025

Jul 09, 2025

Jasper Therapeutics: A Strategic Gamble on Capital Efficiency and Clinical Focus Ahead of Pivotal Data - AInvest

Jul 09, 2025

Jul 09, 2025

Jasper Therapeutics falls after halting clinical programs - TradingView

Jul 09, 2025

Jul 09, 2025

Jasper Therapeutics Announces 50% Workforce Reduction And Strategic Refocus On Chronic Urticaria Programs To Extend Cash Runway And Advance Briquilimab Development - 富途牛牛

Jul 09, 2025